An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06094556 · RECRUITING

Trial details

NCT number: NCT06094556
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-12-25
Primary completion: 2027-06-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.